
As AI-powered diagnostic tools multiply, primary care physicians face a pressing question: which ones are actually worth adopting — and how?

Blake Richards is COO of Elucid, a Boston-based medical technology company dedicated to bringing precision patient care, as currently practiced in oncology, to cardiology. He has extensive healthcare technology experience, including leading revenue cycle and patient confidentiality for Epic Systems, as a life sciences strategy management consultant for Deloitte, and in strategy for several imaging- and AI-driven medical technology start-ups.

As AI-powered diagnostic tools multiply, primary care physicians face a pressing question: which ones are actually worth adopting — and how?